Abstract：The assessment system for professionals with expertise in traditional Chinese medicine is a major measure to promote the inheritance and innovative development of Chinese medicine under the background of the “traditional Chinese medicine law”. At present, the assessment system is still in the trial and exploration stage, and it faces many problems and challenges in actual progess. This article fully understands the current situation of the assessment system, and comprehensively sorts out and analyzes the material review link and the problems existing in the assessment link of the assessment system through methods such as literature search, material collection and expert interviews. This article finds that the main problems in the current assessment system are mainly these: some substantive conditions are required to be reduced, leading to increased risk factors, some assessment dimensions lack assessment standards, and the list of disease names and technical names for candidates to fill in is not complete and derived. The industrial chain of training institutions that has been released has increased the difficulty of review and supervision. In the end, this article puts forward the following suggestions in response to the problem: relevant departments should further improve the operability evaluation indicators, strictly abide by the “strict evaluation” evaluation standards, improve the list of disease names and technical names, increase regulatory enforcement and qualification review, and improve local Chinese medicine management system, etc. These suggestions provide a reference for comprehensively and smoothly advancing the work of the assessment system and improving relevant policies and regulations.
罗鲜 然娜·阿哈提 杨子 张欣雨 贺楠 王薇 范霖杰 李丹 李瑞锋. 《中医药法》背景下考核制工作问题与对策研究[J]. 中国医药导报, 2021, 18(23): 193-196.
LUO Xian Ranna·Ahati YANG Zi ZHANG Xinyu HE Nan WANG Wei FAN Linjie LI Dan LI Ruifeng. Research on the problems and countermeasures of the assessment system under the background of “traditional Chinese medicine law”. 中国医药导报, 2021, 18(23): 193-196.
京公网安备 11010502046598号